Investing.com - Axsome Therapeutics Inc (NASDAQ: AXSM ) reported first quarter EPS of $-1.22, $0.08 better than the analyst estimate of $-1.30. Revenue for the quarter came in at $121.46M versus the consensus estimate of $121.58M. Axsome Therapeutics Inc's stock price closed at $112.21. It is down -1.57% in the last 3 months and up 47.76% in the last 12 months. Axsome Therapeutics Inc saw 0 positive EPS revisions and 7 negative EPS revisions in the last 90 days. See Axsome Therapeutics Inc's stock price's past reactions to earnings here. According to InvestingPro, Axsome Therapeutics Inc's Financial Health score is " fair performance ". Check out Axsome Therapeutics Inc's recent earnings performance, and Axsome Therapeutics Inc's financials here. Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar